Covid-19 vaccines: Priorities, processes and practicalities

As vaccines become available, new challenges await, including managing delivery systems, tracking outcomes, and winning over those still hesitant about the benefits of vaccination

Researchers in a laboratory under Yisheng Biopharma, one of the firms developing a Covid-19 vaccine, in Shenyang, China. Initial supplies of vaccines will be limited because of strong global demand and urgent needs in countries facing Covid-19 surges
Researchers in a laboratory under Yisheng Biopharma, one of the firms developing a Covid-19 vaccine, in Shenyang, China. Initial supplies of vaccines will be limited because of strong global demand and urgent needs in countries facing Covid-19 surges, but as vaccine production ramps up worldwide, supplies should eventually be sufficient for everyone living in Singapore to get vaccinated, say the writers.PHOTO: AGENCE FRANCE-PRESSE

With Covid-19 flaring up again in many countries, and safe, effective vaccines likely to become available over the next few months, how do we deploy them wisely and well?

Globally, the Covid-19 Vaccine Global Access (Covax) Facility is working on vaccine access for all who need it, including low-and medium-income countries. This international collaboration aims to enable equitable distribution of Covid-19 vaccines through global risk-sharing and pooled procurement strategies.

Please or to continue reading the full article.

Get unlimited access to all stories at $0.99/month

  • Latest headlines and exclusive stories
  • In-depth analyses and award-winning multimedia content
  • Get access to all with our no-contract promotional package at only $0.99/month for the first 3 months*

*Terms and conditions apply.

A version of this article appeared in the print edition of The Straits Times on December 01, 2020, with the headline 'Covid-19 vaccines: Priorities, processes and practicalities'. Print Edition | Subscribe